Altogether, these data demonstrate that overexpression of ZNF217-ΔE4 in breast cancer cells enhances their aggressiveness and that the impact of ZNF217-ΔE4 expression on the phenotype of breast cancer cells seems to be at least as or more efficient than that of ZNF217-WT. The gene discussed is ZNF217; the disease is breast carcinoma.